Sublingual and IV Options Sublingual (under the tongue) and IV (intravenous) methods bypass the digestive system entirely
Similarly, SGLT2 inhibitors have demonstrated robust cardiovascular and renal benefits, including reductions in cardiovascular events and all-cause mortality, with consistent effects across the drug class and irrespective of diabetes status [6, 7] Their metabolic benefitssuch as weight loss, improved lipid profiles, and reduced visceral adipositycontribute to a favourable cardiovascular risk profile, countering the pro-atherogenic state typical of T2DM [8]
It was edited by Rebecca Ramirez
Theyll be the ones that adapt thoughtfully: pharma players who can scale manufacturing while maintaining quality, QSR chains that evolve their menus without losing their core appeal, insurance companies that find ways to balance coverage with sustainability, and digital health platforms that bridge the gap between innovation and accessibility
This process results in loose or watery stools
Heres how
